Descriptions:
Term | description type | Language/acceptability | Language/acceptability | Case significance |
---|---|---|---|---|
Product containing precisely [substance][number][Unit of measure ]/[1] each [dose form] (clinical drug) | FSN | us:P | gb:P | ci |
[substance] [number] [Unit of measure ] [dose form] | SYN | us:P | gb:P | ci |
Concept model:
Attribute cardinality | Attribute | Value | role group number | role group cardinality |
---|---|---|---|---|
0 | N/A | |||
1..1 | 0 | 1..1 | ||
1..1 | 0 | 1..1 | ||
1..1 | 0 | 1..1 | ||
0..1 | 0 | 0..1 | ||
0..1 | 0 | 0..1 | ||
1..1 | 1..* | 1..* | ||
1..1 | 1..* | |||
1..1 | 1..* | |||
1..1 | 1..* | |||
1..1 | 1..* | |||
0..1 | 1..* |
Definition status:
900000000000073002 |Defined (core metadata concept)|
Rules for description generation:
- Apply General rules for generating descriptions for templates
For multiple ingredients, the BoSS substance ingredients in each description need to be in alphabetical order
For multiple ingredients, for FSN add 'and [substance][number][Unit of measure ]' after the first [substance][number][Unit of measure ] for each |Has basis of strength substance (attribute)| Example: 413382007 |Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug)|.
For multiple ingredients PT - add ' [substance][number][Unit of measure ] and' at the beginning of the PT Example; Abacavir 600 mg and lamivudine 300 mg oral tablet
- DRUGS-548Getting issue details... STATUS